Skip to main content
Equibles

SHILPAMED · Shilpa Medicare Limited · Financials

Use SHILPAMED with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SHILPAMED.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
993.10 INR +5.70 (+0.58%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 61.46K Avg daily vol (3M) 63.39K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
15.39B +19.6%
FY2026 Revenue FY2018–FY2026
Net Income
2.43B
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
3.42B +158.9%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2020 FY2018
INR 18.42B 15.39B 12.86B 11.52B 10.5B 11.46B 9.08B 7.92B
INR 1.3B 1.2B 1.13B 1.08B 954.99M 798.02M 437.77M 372.22M
INR 491.22M 587.9M 755.33M 918.09M 586.52M 411.65M 45.58M 26.61M
INR — 2.95B — — — 1.02B — —
INR 504.41M 519.8M 440.36M 223.86M -73.64M 416.83M 334.92M 339.06M
INR 2.88B 2.43B 0 0 -324.76M 606.62M 1.56B 1.04B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 282.96M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.